Authors' Reply
- PMID: 32606033
- PMCID: PMC7350994
- DOI: 10.1681/ASN.2020050624
Authors' Reply
Comment on
-
Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial.J Am Soc Nephrol. 2020 May;31(5):1118-1127. doi: 10.1681/ASN.2019090972. Epub 2020 Apr 6. J Am Soc Nephrol. 2020. PMID: 32253271 Free PMC article. Clinical Trial.
-
At the Crossroads for Intravenous Iron Dosing.J Am Soc Nephrol. 2020 Jul;31(7):1653-1654. doi: 10.1681/ASN.2020040540. Epub 2020 Jun 1. J Am Soc Nephrol. 2020. PMID: 32606032 Free PMC article. No abstract available.
References
-
- Bailie GR, Larkina M, Goodkin DA, Li Y, Pisoni RL, Bieber B, et al. .: Variation in intravenous iron use internationally and over time: The dialysis outcomes and practice patterns study (DOPPS). Nephrol Dial Transplant 28: 2570–2579, 2013. - PubMed
-
- Kuragano T, Matsumura O, Matsuda A, Hara T, Kiyomoto H, Murata T, et al. .: Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients. Kidney Int 86: 845–854, 2014. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources